XRCC3基因多态性与西北地区妇女乳腺癌的关联性研究

doi:10.3969/j.issn.1004-616x.2019.05.010

癌变·畸变·突变 ›› 2019, Vol. 31 ›› Issue (5): 392-396,400.doi: 10.3969/j.issn.1004-616x.2019.05.010

XRCC3基因多态性与西北地区妇女乳腺癌的关联性研究

王兰¹, 张永东¹, 郭红云¹, 王涛¹, 王海涛¹, 郭欢¹, 杨碎胜², 李晓琴³, 苏海翔¹

1. 甘肃省医学科学研究院转化医学研究中心, 甘肃兰州 730050;
2. 甘肃省肿瘤医院乳腺肿瘤外科, 甘肃兰州 730050;
3. 甘肃省肿瘤医院病理诊断中心, 甘肃兰州 730050

收稿日期:2018-12-11 修回日期:2019-06-29 出版日期:2019-09-30 发布日期:2019-10-09
通讯作者: 苏海翔,E-mail:haixiang256@163.com E-mail:haixiang256@163.com
作者简介:王兰,E-mail:wala6535@163.com。
基金资助:
甘肃省自然科学基金项目（1606RJZA148）；甘肃省科技计划资助项目（17JR3TA013）；11批甘肃科学技术支持项目（1011FKCA089）

Relationships between XRCC3 polymorphisms and breast cancer in northern Chinese women

WANG Lan¹, ZHANG Yongdong¹, GUO Hongyun¹, WANG Tao¹, WANG Haitao¹, GUO Huan¹, YANG Suisheng², LI Xiaoqin³, SU Haixiang¹

1. Center of Translational-Medicine Research, Gansu-Provincial Academy of Medical Sciences, Lanzhou 730050;
2. Breast Tumor Surgery, Gansu-Provincial Cancer Hospital, Lanzhou 730050;
3. Pathological Diagnosis Center, Gansu-Provincial Cancer Hospital, Lanzhou 730050, Gansu, China

Received:2018-12-11 Revised:2019-06-29 Online:2019-09-30 Published:2019-10-09

摘要/Abstract

摘要： 目的：通过对中国西北地区妇女乳腺癌与健康人群XRCC3基因多态性位点的研究，找出基因多态性与乳腺癌发病的相关性。方法：采集西北地区的517例乳腺癌患者和1 008例健康人群外周血，提取DNA后采用高通量芯片检测方法，测定XRCC3基因rs861534、rs861537、rs3212092和rs861530共4个多态性位点的基因分型。结果：Logistic回归分析发现XRCC3 rs861534位点的AG/AA基因型，病例组与对照组比较差异有统计学意义（P < 0.01，OR=0.36；P=0.013，OR=0.08），同时，GG+AG基因型与对照组比较差异有统计学意义（P < 0.01），XRCC3 rs861530位点的Logistic回归分析显示AG+AA基因型与对照组比较差异有统计学意义（P=0.044）。相关临床病理学指标分析显示rs861537位点的GG/AG基因型在ER⁺与ER^-患者中的分布差异有统计学意义（P=0.048，OR=1.50）。rs3212092位点的CC+CT基因型在Her-2^-与Her-2⁺患者中的分布差异具有统计学意义（P=0.027，OR=2.06）。结论：在中国西北地区妇女人群中XRCC3基因rs861534和rs861530两个位点的多态性与乳腺癌的发病有相关性。在XRCC3 rs861537位点，GG/AG基因型ER⁺携带者可能具有较高的乳腺癌内分泌治疗风险；在rs3212092位点，携带CT和TT基因型的Her-2⁺表达患者具有明显的乳腺癌转移复发风险。

关键词: 乳腺癌, 相关性分析, 单核苷酸多态性, XRCC3基因

Abstract: OBJECTIVE:To investigate correlations between gene polymorphisms and cancer,we studied polymorphisms in the XRCC3 double strand DNA repair gene in breast cancer. METHODS:Data on four gene loci (rs861534,rs861537,rs3212092 and rs861530) were combined with genotypes on breast cancer. High throughput chip detection assay was used for the polymorphism of XRCC3 in 517 cases of breast cancer and 1 008 disease-free controls which were collected in Gansu. RESULTS:With logistic regression analyses of the polymorphisms,rs861534 was found have significantly different distributions at the AG/AA genotype (P < 0.01,OR=0.36;P=0.013,OR=0.08) compared with the-GG-allele. The rs861530 AG+AA alleles-were significantly different from the controls (P=0.044). With respect to clinical indicators,the rs861537 GG/AG genotype was significant associated with positive ER protein (P=0.048,OR=1.50). In tumer tissues,the rs3212092 CT genotype was significantly associated with the Her-2⁺ protein (P=0.049),while the CC+CT genotype was significantly different (P=0.027,OR=2.06). CONCLUSION:Our results indicate that-XRCC3 rs861534 and rs861530-were significant associated with breast cancer risk. The GG/AG genotype with ER⁺ at XRCC3 rs861537 may impose a higher risk for breast cancer. Patients with the positive of ER protein and with the rs861537 locus may have increased risk from endocrine therapy. After adjusting for covariates,the rs3212092 homozygote TT-and heterozygote CT with Her-2⁺ expression were associated with the risk of recurrence and metastasis.

Key words: breast cancer, correlation analysis, single nucleotide polymorphisms, XRCC3 gene

中图分类号:

R730.2

王兰, 张永东, 郭红云, 王涛, 王海涛, 郭欢, 杨碎胜, 李晓琴, 苏海翔. XRCC3基因多态性与西北地区妇女乳腺癌的关联性研究[J]. 癌变·畸变·突变, 2019, 31(5): 392-396,400.

WANG Lan, ZHANG Yongdong, GUO Hongyun, WANG Tao, WANG Haitao, GUO Huan, YANG Suisheng, LI Xiaoqin, SU Haixiang. Relationships between XRCC3 polymorphisms and breast cancer in northern Chinese women[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(5): 392-396,400.

参考文献

[1] 宋宛芝, 高晋南, 杨海波. 乳腺癌的流行状况及发病特征[J]. 中国药物与临床, 2017, 17(2):228-229.
[2] FU X J, SHI X J, LIN K, et al. Environmental and DNA repair risk factors for breast cancer in South China[J]. Int J Hyg Environ Health, 2015, 218(3):313-318.
[3] SILVA S N, TOMAR M, PAULO C, et al. Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51[J]. Cancer Epidemiol, 2010, 34(1):85-92.
[4] LOIZIDOU M A, MICHAEL T, NEUHAUSEN S L, et al. Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus[J]. Breast Cancer Res Treat, 2008, 112(3):575-579.
[5] SMOLARZ B, MAKOWSKA M, SAMULAK D, et al. Association between single nucleotide polymorphisms (SNPs) of XRCC2 and XRCC3 homologous recombination repair genes and triple-negative breast cancer in Polish women[J]. Clin Exp Med, 2015, 15(2):151-157.
[6] PETER A, STICK R. Evolution of the lamin protein family:what introns can tell[J]. Nucleus, 2012, 3(1):44-59.
[7] BROMBERG Y, CAPRIOTTI E. SNP-SIG Meeting 2011:identification and annotation of SNPs in the context of structure, function, and disease[J]. BMC Genomics, 2012, 13(Suppl 4):S1.
[8] LIEBEN L. Disease genetics:SNP location helps predict disease aetiology[J]. Nat Rev Genet, 2016, 17(1):4.
[9] WU H C, DELGADO-CRUZATA L, MACHELLA N, et al. DNA double-strand break repair genotype and phenotype and breast cancer risk within sisters from the New York site of the Breast Cancer Family Registry (BCFR)[J]. Cancer Causes Control, 2013, 24(12):2157-2168.
[10] FLEISCHER T, EDVARDSEN H, SOLVANG H K, et al. Integrated analysis of high-resolution DNA methylation profiles, gene expression, germline genotypes and clinical end points in breast cancer patients[J]. Int J Cancer, 2014, 134(11):2615-2625.
[11] 李兴慧, 张一心, 刘继斌, 等. XRCC基因多态性与乳腺癌关系的研究进展[J]. 现代肿瘤医学, 2015, 23(2):284-288.
[12] FIGUEIREDO J C, KNIGHT J A, BRIOLLAIS L, et al. Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the breast cancer family registry[J]. Cancer Epidemiol Biomarkers Prev, 2004, 13(4):583-591.
[13] KUSCHEL B, AURANEN A, MCBRIDE S, et al. Variants in DNA double-strand break repair genes and breast cancer susceptibility[J]. Hum Mol Genet,2002, 11(12):1399-1407.
[14] LEE S A, LEE K M, PARK S K, et al. Genetic polymorphism of XRCC3 Thr241Met and breast cancer risk:case-control study in Korean women and meta-analysis of 12 studies[J]. Breast Cancer Res Treat, 2007, 103(1):71-76.
[15] ALI A M, ABDULKAREEM H, AL ANAZI M, et al. Polymorphisms in DNA repair gene XRCC3 and susceptibility to breast cancer in saudi females[J]. Biomed Res Int, 2016, 2016:8721052.
[16] WEEDEN C E, ASSELIN-LABAT M L. Mechanisms of DNA damage repair in adult stem cells and implications for cancer formation[J]. Biochim Biophys Acta Mol Basis Dis, 2018, 1864(1):89-101.
[17] NGUYEN T L, SCHMIDT D F, MAKALIC E, et al. Explaining variance in the cumulus mammographic measures that predict breast cancer risk:a twins and sisters study[J]. Cancer Epidemiol Biomarkers Prev, 2013, 22(12):2395-2403.
[18] 谢云, 张楠, 梁翠微, 等. 新辅助化疗对乳腺癌患者雌激素受体及表皮生长因子受体-2表达的影响[J]. 中国肿瘤临床与康复, 2017, 24(9):1060-1063.
[19] SELCUKBIRICIK F, ERDAMAR S, BUYUKUNAL E, et al. Is Her-2 status in the primary tumor correlated with matched lymph node metastases in patients with gastric cancer undergoing curative gastrectomy?[J]. Asian Pac J Cancer Prev, 2014, 15(24):10607-10611.
[20] TOMIGUCHI M, YAMAMOTO Y, YAMAMOTO-IBUSUKI M, et al. Fibroblast growth factor receptor-1 protein expression is associated with prognosis in estrogen receptor-positive/human epidermal growth factor receptor-2-negative primary breast cancer[J]. Cancer Sci, 2016, 107(4):491-498.
[21] MAO C F, QIAN W Y, WU J Z, et al. Association between the XRCC3 Thr241Met polymorphism and breast cancer risk:an updated meta-analysis of 36 case-control studies[J]. Asian Pac J Cancer Prev, 2014, 15(16):6613-6618.
[22] INOUE K, FRY E A. Novel molecular markers for breast cancer[J]. Biomark Cancer, 2016, 8:BIC.S38394.

XRCC3基因多态性与西北地区妇女乳腺癌的关联性研究

Relationships between XRCC3 polymorphisms and breast cancer in northern Chinese women

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	辛雨濛, 梁桓熙, 余悦华, 孙震晓. 基于网络药理学和分子对接法预测甘草干姜汤抗乳腺癌的主要活性成分及作用机制[J]. 癌变·畸变·突变, 2022, 34(1): 7-13.
[2]	赵岩, 孙震晓. 二甲双胍抑制人MDA-MB-231细胞增殖及迁移的体外实验研究[J]. 癌变·畸变·突变, 2022, 34(1): 35-39.
[3]	方煜彤, 张群琛, 洪超群, 陈春发, 陈炯玉, 张任栋, 吴俊东. 乳腺癌中miR-221、miR-222表达水平对GATA3和FOXA1蛋白的影响及其作用机制[J]. 癌变·畸变·突变, 2021, 33(6): 435-441,460.
[4]	张世民, 赵瑞君. 蛋白酪氨酸磷酸酶受体J在乳腺癌组织中的表达及其与临床预后的相关性[J]. 癌变·畸变·突变, 2021, 33(4): 276-279,285.
[5]	程斌, 王新宇, 孙钰, 张家泰, 董淑英. 二甲双胍对DEHP和DBP诱导的MCF-7细胞增殖和迁移的抑制作用[J]. 癌变·畸变·突变, 2021, 33(3): 197-202.
[6]	罗娇, 张坤驰, 周莉. 三阴性乳腺癌细胞系MDA-MB-231与其脑转移细胞系中microRNA差异表达分析[J]. 癌变·畸变·突变, 2021, 33(3): 218-224.
[7]	李玮玮, 朱莹. 数据挖掘分析MYB家族在乳腺癌中的表达及其预后评估价值[J]. 癌变·畸变·突变, 2020, 32(6): 414-422.
[8]	吕燕萍, 吴传城, 杨双凤, 何陈周, 韩仁杰, 颜伟, 刘宝英. 胃癌差异表达miRNA及其相关基因的单核苷酸多态性与胃癌预后的相关性研究[J]. 癌变·畸变·突变, 2020, 32(5): 380-386.
[9]	陈绵龄, 马硕一. miR-21通过靶向PDCD4调控三阴性乳腺癌细胞的迁移和侵袭[J]. 癌变·畸变·突变, 2020, 32(4): 292-297.
[10]	张惠娟, 黄大元, 张洁, 唐海欧, 谢安心, 谭敦勇. SF1a-PRLR和ΔS2 SF1a-PRLR对乳腺癌MCF-7细胞增殖和microRNA表达的影响[J]. 癌变·畸变·突变, 2020, 32(3): 203-208.
[11]	舒智雄, 吴传城, 吴晓丽, 刘宝英. 基于SNP芯片研究PI3K/Akt/mTOR通路上自噬相关基因SNPs与胃癌的关联[J]. 癌变·畸变·突变, 2020, 32(2): 118-125,131.
[12]	马晓骉, 张麒, 潘定国. B7-H1基因rs4143815位点多态性与结直肠癌发病风险的关联研究[J]. 癌变·畸变·突变, 2019, 31(6): 440-443,448.
[13]	孙全武, 杜小平, 郝杰, 时荣, 刘波, 黄海云. 伴病理性乳头溢液的乳腺癌患者癌组织整合素β1的表达及意义[J]. 癌变·畸变·突变, 2019, 31(5): 368-372.
[14]	应伟, 王兴远, 江波, 周伟. miR-146a多态性与非小细胞肺癌易感性的研究[J]. 癌变·畸变·突变, 2019, 31(3): 222-226.
[15]	梁辰, 靳翠红. 乳腺癌易感基因1调控氧化损伤在神经退行性疾病中作用的研究进展[J]. 癌变·畸变·突变, 2019, 31(3): 257-260.